Evidence map›Paper›PMID 23820730›Full record

ArticleMolecular & cellular proteomics : MCP2013

Proteomic analysis of the SH2 domain-containing leukocyte protein of 76 kDa (SLP76) interactome in resting and activated primary mast cells [corrected].

Yacine Bounab, Anne-Marie- Hesse, Bruno Iannascoli, Luca Grieco, Yohann Couté, Anna Niarakis, Romain Roncagalli, Eunkyung Lie, Kong-Peng Lam, Caroline Demangel and 4 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Yacine BounabInstitut Pasteur, Département d'Immunologie, Unité d'Allergologie Moléculaire et Cellulaire, and Centre d'Immunologie Humaine Paris, France;
Anne-Marie- Hesse
Bruno Iannascoli
Luca Grieco
Yohann Couté
Anna Niarakis
Romain Roncagalli
Eunkyung Lie
Kong-Peng Lam
Caroline Demangel
Denis Thieffry
Jérôme Garin
Bernard Malissen
Marc Daëron
Centre National de la Recherche Scientifique · FRInserm · FRAgency for Science, Technology and Research · SGInstitut Pasteur · FRKorea Advanced Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the first proteomic analysis of the SLP76 interactome in resting and activated primary mouse mast cells. This was made possible by a novel genetic approach used for the first time here. It consists in generating knock-in mice that express signaling molecules bearing a C-terminal tag that has a high affinity for a streptavidin analog. Tagged molecules can be used as molecular baits to affinity-purify the molecular complex in which they are engaged, which can then be studied by mass spectrometry. We examined first SLP76 because, although this cytosolic adapter is critical for both T cell and mast cell activation, its role is well known in T cells but not in mast cells. Tagged SLP76 was expressed in physiological amounts and fully functional in mast cells. We unexpectedly found that SLP76 is exquisitely sensitive to mast cell granular proteases, that Zn(2+)-dependent metalloproteases are especially abundant in mast cells and that they were responsible for SLP76 degradation. Adding a Zn(2+) chelator fully protected SLP76 in mast cell lysates, thereby enabling an efficient affinity-purification of this adapter with its partners. Label-free quantitative mass spectrometry analysis of affinity-purified SLP76 interactomes uncovered both partners already described in T cells and novel partners seen in mast cells only. Noticeably, molecules inducibly recruited in both cell types primarily concur to activation signals, whereas molecules recruited in activated mast cells only are mostly associated with inhibition signals. The transmembrane adapter LAT2, and the serine/threonine kinase with an exchange factor activity Bcr were the most recruited molecules. Biochemical and functional validations established the unexpected finding that Bcr is recruited by SLP76 and positively regulates antigen-induced mast cell activation. Knock-in mice expressing tagged molecules with a normal tissue distribution and expression therefore provide potent novel tools to investigate signalosomes and to uncover novel signaling molecules in mast cells.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBone Marrow CellsCells, CulturedMast CellsMiceMice, Inbred C57BLMice, TransgenicPhosphoproteinsProtein Interaction MapsProteomicsProto-Oncogene Proteins c-bcrReceptors, IgEAdaptor Proteins, Signal TransducingBcr protein, mousePhosphoproteinsProto-Oncogene Proteins c-bcrReceptors, IgESLP-76 signal Transducing adaptor proteins

Identifiers

PMID23820730
PMCPMC3790297
OpenAlexW1964810486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.